| Ponatinib |
Influence on protein activity in presence of bFGF |
Western Blot |
5.00 µM |
NGP |
Homo sapiens |
|
p-STAT3 (Y705) |
|
| Ponatinib |
Influence on protein activity in presence of bFGF |
Western Blot |
10.00 µM |
NGP |
Homo sapiens |
|
p-STAT3 (Y705) |
|
| Ponatinib |
Influence on protein activity in presence of bFGF |
Western Blot |
20.00 µM |
NGP |
Homo sapiens |
|
p-STAT3 (Y705) |
|
| Ponatinib |
Influence on protein activity in presence of bFGF |
Western Blot |
2.00 µM |
SH-SY5Y |
Homo sapiens |
|
p-STAT3 (Y705) |
|
| Ponatinib |
Influence on protein activity in presence of bFGF |
Western Blot |
5.00 µM |
SH-SY5Y |
Homo sapiens |
|
p-STAT3 (Y705) |
|
| Ponatinib |
Influence on protein activity in presence of bFGF |
Western Blot |
10.00 µM |
SH-SY5Y |
Homo sapiens |
|
p-STAT3 (Y705) |
|
| Ponatinib |
Influence on protein activity in presence of bFGF |
Western Blot |
20.00 µM |
SH-SY5Y |
Homo sapiens |
|
p-STAT3 (Y705) |
|
| Ponatinib |
Influence on protein activity in tumor tissue |
Western Blot |
15.00 mg/kg |
NB-19 (xenograft) |
Mus musculus |
NCr nude mice |
p-STAT3 (Y705) |
|
